Follow us...

 

Search News Archives

Monthly Newsletter

 

Lab Bulletin May Newsletter

view the latest issue

Subscribe

News Channels

 

New Laboratory Products

 

Lab News

 

Microscopy & Image Analysis

 

Separation Science

 

Research & Case Studies

 

Literature

 

Videos

 

Events | Webinars

 

 

 

Conferences | Events

NY State Hospital Ready for Ebola Fight with Bioquell Robots

publication date: Dec 15, 2014
 | 
author/source: Bioquell

With Ebola cases reaching the USA, the public has become more conscious about infectious diseases and infection control.

bioquellHospitals face the challenge of infection prevention on a daily basis. Whilst some are in the process of setting up Ebola preparedness protocols, some like the Rome Memorial Hospital, New York, are already fully equipped to handle a case should it present itself.

As broadcasted in two features on WKTV News and CNY, Rome Memorial already uses Bioquell’s hydrogen peroxide vapour (HPV) technology to fight more common infections.  Leanna Grace with the infection prevention team at the Rome hospital says, "That's part of our plan.  When the patient leaves here the room has to be cleaned first.  And we'd have people in special protective equipment to clean the room and then we would put the Bioquell [robot in] and then it would take care of whatever might be lingering."

Bioquell’s HPV technology is the solution of choice for the decontamination of rooms, ambulances and other equipments that have been in contact with Ebola patients. HPV is recommended in many Ebola preparedness protocols as it has robust and documented proof about its ability to eradicate a wide variety of pathogens to a 99.9999% reduction.

Bioquell room bio-decontamination service (RBDS) has intervened on many Ebola cases around the world and many hospitals have invested in the technology for themselves. They use it every day to prevent the spread of other more common pathogens such as CPE, C.difficle or norovirus.

Bioquell’s hydrogen peroxide vapour is the gold standard for efficacy. Numerous studies with prestigious institutions such as Johns Hopkins and Yale have shown Bioquell HPV reduces infection rates for spore-forming pathogens. Speaking about the Bioquell process, Leanna Grace explains, “We did cultures before they did it and we did cultures after. We had positive cultures before and when we did them after, they were all negative except one, where we had done a little bit of dirt. Normally, you can't sterilize through any kind of [solid/dirt] matter."


more about bioquell


more news from bioquell



If you have not logged into the website then please enter your details below.



 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 


Promotions

 

Media Partners